Patents for B82Y 5 - Nano-biotechnology or nano-medicine, e.g. protein engineering or drug delivery (2,162)
08/2011
08/11/2011US20110195111 Aqueous compositions and methods
08/11/2011US20110195095 Injectable nanoparticulate olanzapine formulations
08/11/2011US20110192800 Magnetic-cored dendrimer, the method for preparing the same, and the contaminant treatment method using the same
08/11/2011US20110192723 Systems and methods for manipulating a molecule in a nanopore
08/04/2011US20110190399 Curcumin nanoparticles and methods of producing the same
08/04/2011US20110189446 Process and System for Fabrication of Patterns on a Surface
08/04/2011US20110189343 Nano-sized lactic acid bacteria
08/04/2011US20110189287 Methods and compositions for wound healing
08/04/2011US20110189268 Inhibition of Placenta Growth Factor (PLGF) Mediated Metastasis and/or Angiogenesis
08/04/2011US20110189266 Corticosteroid microvesicles for treatment of cardiovascular diseases
08/04/2011US20110189257 Nanoparticle based therapy for aggregating mucin
08/04/2011US20110189101 Fluorescent labeling agent and fluorescent labeling method
08/03/2011EP2351610A2 Nano-particle biochip substrates
08/03/2011EP2349340A2 Stable aqueous formulations of water insoluble or poorly soluble drugs
07/2011
07/28/2011US20110184196 Preparation of azide-modified carbon surfaces for coupling to various species
07/28/2011US20110184053 Novel nucleic acid transfer system
07/28/2011US20110183908 Yopm as delivery vehicle for cargo molecules and as biological therapeutic for immunomodulation of inflammatory reactions
07/28/2011US20110183140 Method for Polymer Coating and Functionalization of Metal Nanorods
07/28/2011US20110182999 Ceramide dispersion and method for producing same
07/28/2011US20110182994 Methods and systems for production of nanoparticles
07/28/2011US20110182988 Gastroretentive pharmaceutical dosage form
07/28/2011US20110182987 Pharmaceutical dosage form for the site-specific delivery of more than one active pharmaceutical ingredient
07/28/2011US20110182973 Polymerase inhibitors and the use thereof for the treatment of tumors
07/28/2011US20110182948 Method for treating disease characterized by plaque
07/28/2011US20110182946 Formation of Nanostructured Particles of Poorly Water Soluble Drugs and Recovery by Mechanical Techniques
07/28/2011US20110182814 Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma
07/28/2011US20110180427 Method for Sensing a Substance to be Detected in a Sample
07/21/2011WO2011086210A1 Magnetic-luminescent particles for biomedical uses
07/21/2011US20110178182 Enriched nanostructure composition
07/21/2011US20110177951 Microcapsules comprising active ingredients and a metal oxide shell, a method for their preparation and uses thereof
07/21/2011US20110177169 Ophthalmic formulations of reversed liquid crystalline phase materials and methods of using
07/21/2011US20110177154 Tubular nanostructure targeted to cell membrane
07/21/2011US20110177153 targeted nanoparticle drug for magnetic hyperthermia treatment on malignant tumors
07/21/2011US20110177139 Solid microstructure that enables multiple controlled release and method of maufacturing same
07/21/2011US20110177131 siRNA SILENCING OF FILOVIRUS GENE EXPRESSION
07/21/2011US20110177009 Drug carrier providing mri contrast enhancement
07/21/2011US20110176962 Quantum dot-based environmental indicators
07/21/2011US20110176655 System and Method for Tomosynthesis
07/20/2011EP2345453A2 System for RF-induced hyperthermia
07/14/2011US20110172523 Surface enhanced spectroscopy-active composite nanoparticles
07/14/2011US20110172486 Magnetic microbubbles, methods of preparing them and their uses
07/14/2011US20110172404 Self-Assembly of Nanoparticles Through Nuclei Acid Engineering
07/14/2011US20110171715 Biocompatible polymer and magnetic nanoparticle with biocompatibility
07/14/2011US20110171305 Dehydrated hydrogel inclusion complex of a bioactive agent with flowable drug delivery system
07/14/2011US20110171276 Non-Viral Compositions and Methods for Transfecting Gut Cells In Vivo
07/14/2011US20110171269 Method for manufacturing uniform size polymeric nanoparticles containing poorly soluble drugs
07/14/2011US20110171140 Absorption of therapeutic agents across mucosal membranes or the skin
07/14/2011US20110171137 Novel nanostructures and process of preparing same
07/14/2011CA2784704A1 Temperature-dependent activation of catalytic nucleic acids for controlled active substance release
07/13/2011EP2342338A1 Systems and methods for magnetic guidance and patterning of cells and materials
07/13/2011EP2341897A2 Nanoparticles for immunotherapy
07/07/2011US20110165587 Method for live-cell activity assay
07/07/2011US20110165254 Drug Delivery Using Fine Fiber Encapsulation
07/07/2011US20110165251 Liquid dosage compositions of stable nanoparticulate active agents
07/07/2011US20110165227 Compositions and Methods Using siRNA Molecules for Treatment of Gliomas
07/07/2011US20110165225 Modified Drugs for Use in Liposomal Nanoparticles
07/07/2011US20110165207 Particulate wax composites and method for the production thereof and the use thereof
07/07/2011US20110165206 Preparation of Silicone Microemulsions
07/07/2011US20110165205 Nanovector with positive charge substantive for hair and skin
07/07/2011US20110165086 Iron oxide nanoparticles as mri contrast agents and their preparing method
07/07/2011US20110165070 Methods for radiolabeling synthetic polymers
07/07/2011US20110165069 Methods for radiolabeling macromolecules
07/07/2011US20110165068 Liposome medicament, method of preparation and use thereof
07/07/2011US20110165064 Methods and compositions related to clot-binding compounds
07/06/2011EP2340811A1 Ph-sensitive block copolymer forming polyionic complex micelles and drug or protein carrier using the same
06/2011
06/30/2011WO2011079290A1 Oligonucleotide specific uptake of nanoconjugates
06/30/2011US20110160694 Nanotubes as Mitochondrial Uncouplers
06/30/2011US20110160230 Ceramic matrix for incorporating controlled release drugs, a tablet, method for obtaining the ceramic matrix and method for producing a tablet
06/30/2011US20110159291 Solution stable and chemically reactive metallic nanoparticles
06/30/2011US20110159273 Method for coating surfaces with micro- and nanoparticles with the aid of plasma methods
06/30/2011US20110159083 Nanoparticles for protein drug delivery
06/30/2011US20110159070 Biomaterials and implants for enhanced cartilage formation, and methods for making and using them
06/30/2011US20110159056 Methods and materials for stimulating proliferation of stem cells
06/30/2011US20110159054 Nanoparticulate bicalutamide formulations
06/30/2011US20110159048 Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications
06/30/2011US20110158910 Microparticles comprising polymers with thioester bonds
06/30/2011US20110158901 Chitosan-based nanoparticles and methods for making and using the same
06/29/2011EP2338505A2 Vault and vault-like carrier molecules
06/29/2011EP2338504A2 Vault and vault-like carrier molecules
06/23/2011WO2011073685A1 Modulator
06/23/2011WO2011073411A1 Nanoparticle clusters formed from individual nanoparticles of two or more types
06/23/2011US20110152751 Systems, devices, and methods including catheters having UV-Energy emitting coatings
06/23/2011US20110151563 Collagen Materials, Films and Methods of Making Same
06/23/2011US20110151013 Amphiphilic block copolymers for nucleic acid delivery
06/23/2011US20110151012 Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents
06/23/2011US20110150987 Mucoadhesive particulate formulation for inducing antigen-specific immune tolerance
06/23/2011US20110150960 Hazardous substance removing material and method for removing hazardous substance
06/23/2011US20110150938 Supercrystalline Colloidal Particles and Method of Production
06/23/2011US20110150897 Influenza targets
06/23/2011US20110150837 Amphiphilic polymer functionalized by methionine
06/23/2011US20110146678 Process for improving crystallinity
06/23/2011CA2783892A1 Modulator
06/22/2011EP2335073A2 In vivo biofilm infection diagnosis and treatment
06/16/2011US20110144559 Medical drainage devices with carbon-based structures for inhibiting growth of fibroblasts
06/16/2011US20110144314 Method for selectively extracting membrane proteins using calixarenes
06/16/2011US20110144163 Thiolated paclitaxels for reaction with gold nanoparticles as drug delivery agents
06/16/2011US20110144030 Conjugate of hyaluronic acid for cosmetic treatment and preparation method
06/16/2011US20110142948 Nanoparticle Carrier Systems based on Human Serum Albumin for Photodynamic Therapy
06/16/2011US20110142947 Novel formulations
06/16/2011US20110142941 Nanoparticle and Polymer Formulations for Thyroid Hormone Analogs, Antagonists, and Formulations and Uses Thereof
1 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 22